Tele-Interpretation of Hepatitis Serology Test Results Integrated Into Soarian

Tele-interpretation by Hepaxpert was successfully established and integrated into Soarian, one of the hospital information systems designed by Siemens Company (Xetra: SIE, NYSE: SI, LSE: SIE, SWX: SIN). Hepaxpert, a clinical decision support system for automated interpretation of hepatitis A,…

Artificial-Intelligence-Augmented Clinical Medicine at MEDICA

At the World Forum for Medicine, International Trade Fair with Congress (MEDICA’06) in Düsseldorf/Germany, our CEO and Scientific Head, Professor Klaus-Peter Adlassnig, gave an invited talk on “Artificial-intelligence-augmented clinical medicine“.

World of Health IT

At the symposium “World of Health IT” in Vienna/Austria, our CEO and Scientific Head, Professor Klaus-Peter Adlassnig, gave an invited talk on “Artificial-intelligence-based monitoring of hospital-acquired infections in adult intensive care patients”.

Hepaxpert – Knowledge-Based Hepatitis Serology Test Result Interpretation

Hepaxpert—a knowledge-based interpretive system for hepatitis A, B, and C serology test results—has now been rendered suitable for production by Medexter Healthcare. It is being routinely used at the Department of Laboratory Diagnosis, Franz Josef Hospital, Vienna, since 1998 onward.…

Invited Talk at MIT Faculty Club, Cambridge

At the 12th Annual Future of Health Technology Summit FHT 2007, MIT Faculty Club in Cambridge/U.S.A., our CEO and Scientific Head, Professor Klaus-Peter Adlassnig, gave an invited talk on “Artificial-intelligence-based hospital infection control”.

Cooperation with the Medical University of Vienna, Austria

A cooperative agreement between the Medical University of Vienna (MUW), Austria, and Medexter Healthcare was signed by the rector of the MUW, Univ.-Prof. Dr. Wolfgang Schütz, and Medexter. This agreement is written confirmation of extensive mutual exchange of ideas and…

Moni IV in Routine Use at the Vienna General Hospital

After an extended development and test phase, the Moni-IV system (knowledge-based identification and automated monitoring of hospital-acquired infections in adult intensive care unit (ICU) patients) could be transferred into routine use at the infection control department of the Vienna General…

Evolution ’07, Graz

At the symposium “Evolution ’07” in Graz/Austria, our CEO and Scientific Head, Professor Klaus-Peter Adlassnig, gave an invited talk on “Clinical decision support”.

Symposium on Processes and Medical Ontologies, Berlin

At the Symposium on Processes and Medical Ontologies that was organized by ID Gesellschaft für Information und Dokumentation im Gesundheitswesen mbH in Berlin/Germany, our CEO and Scientific Head, Professor Klaus-Peter Adlassnig, gave an invited talk on “Partial automation of clinical…

ID Berlin Products Enhanced by Medexter’s Arden Syntax Software

A long-term contract between ID Gesellschaft für Information und Dokumentation im Gesundheitswesen mbH, Berlin, Germany, and Medexter Healthcare has been concluded. The contract permits ID to use Medexter’s medical knowledge representation and inference Arden Syntax software in their products. Thus,…

Arden Syntax Software für Medical Knowledge Representation and Inference

Medexter Healthcare announces the completion of the medical knowledge representation and inference Arden Syntax software. The software is programmed in Java. Its main components are an Arden Syntax IDE, the integrated development environment to write and test Arden Syntax medical…

Telemedical Decision Support in Clinical Medicine

At the Conference for Telemedical Applications and Technologies (TeleHealth 2007) in Hannover/Germany, our CEO and Scientific Head, Professor Klaus-Peter Adlassnig, gave an invited talk on “Telemedical decision support in clinical medicine”.

Contact Us

Let us answer your questions or make you a customized offer.

GET IN TOUCH

Newsletter

Get our newsletter with updates on our CDS developments.

SUBSCRIBE

Microbiology Analytics with Momo

Newsletter 1 / 2018

Read Newsletter

By continuing to use this site, you consent to the use of cookies in accordance to our privacy policy.
Privacy Policy Confirm